Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 7.98805320 |
2 | Golgi transport vesicle coating (GO:0048200) | 7.98805320 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.01314005 |
4 | protein retention in ER lumen (GO:0006621) | 6.50136239 |
5 | cellular response to ATP (GO:0071318) | 6.12863549 |
6 | signal peptide processing (GO:0006465) | 6.07379590 |
7 | COPII vesicle coating (GO:0048208) | 4.94309396 |
8 | protein maturation by protein folding (GO:0022417) | 4.81382468 |
9 | exocrine pancreas development (GO:0031017) | 4.73273131 |
10 | intestinal cholesterol absorption (GO:0030299) | 4.64516322 |
11 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.44187601 |
12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.35336382 |
13 | positive regulation of nuclease activity (GO:0032075) | 4.22906095 |
14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.22045636 |
15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.20821195 |
16 | protein targeting to ER (GO:0045047) | 4.14371766 |
17 | cotranslational protein targeting to membrane (GO:0006613) | 4.09716907 |
18 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.01693006 |
19 | UV protection (GO:0009650) | 4.00908746 |
20 | regulation of nuclease activity (GO:0032069) | 3.97881793 |
21 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.94430524 |
22 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.93493381 |
23 | protein localization to endoplasmic reticulum (GO:0070972) | 3.88692380 |
24 | mannose metabolic process (GO:0006013) | 3.88238254 |
25 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.85663759 |
26 | rRNA methylation (GO:0031167) | 3.85464031 |
27 | cellular response to unfolded protein (GO:0034620) | 3.84631439 |
28 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.81856445 |
29 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.79739919 |
30 | DNA deamination (GO:0045006) | 3.77858915 |
31 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.71788373 |
32 | proline biosynthetic process (GO:0006561) | 3.71252342 |
33 | cellular response to topologically incorrect protein (GO:0035967) | 3.70367077 |
34 | ER-nucleus signaling pathway (GO:0006984) | 3.58333992 |
35 | intestinal absorption (GO:0050892) | 3.58157483 |
36 | rRNA modification (GO:0000154) | 3.55310195 |
37 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.48103729 |
38 | * protein N-linked glycosylation via asparagine (GO:0018279) | 3.44028795 |
39 | endocrine pancreas development (GO:0031018) | 3.39251743 |
40 | * peptidyl-asparagine modification (GO:0018196) | 3.38895332 |
41 | sequestering of metal ion (GO:0051238) | 3.34835542 |
42 | response to endoplasmic reticulum stress (GO:0034976) | 3.33512597 |
43 | ribosomal small subunit assembly (GO:0000028) | 3.32031546 |
44 | NIK/NF-kappaB signaling (GO:0038061) | 3.21263130 |
45 | ER overload response (GO:0006983) | 3.20749390 |
46 | purine ribonucleotide transport (GO:0015868) | 3.17086795 |
47 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.17041990 |
48 | DNA replication checkpoint (GO:0000076) | 3.16699650 |
49 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.13979350 |
50 | * protein N-linked glycosylation (GO:0006487) | 3.12194757 |
51 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.11786270 |
52 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.11706944 |
53 | vesicle coating (GO:0006901) | 3.10157661 |
54 | DNA strand renaturation (GO:0000733) | 3.09943333 |
55 | negative regulation of cell aging (GO:0090344) | 3.08897552 |
56 | response to ATP (GO:0033198) | 3.06889137 |
57 | programmed necrotic cell death (GO:0097300) | 3.04519758 |
58 | response to unfolded protein (GO:0006986) | 3.03186793 |
59 | viral transcription (GO:0019083) | 3.02652775 |
60 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.01215066 |
61 | translational termination (GO:0006415) | 2.96860274 |
62 | protein autoprocessing (GO:0016540) | 2.94306596 |
63 | response to topologically incorrect protein (GO:0035966) | 2.93755694 |
64 | peptide hormone processing (GO:0016486) | 2.93094274 |
65 | mitochondrial calcium ion transport (GO:0006851) | 2.87200974 |
66 | * GDP-mannose metabolic process (GO:0019673) | 2.86327570 |
67 | glutathione biosynthetic process (GO:0006750) | 2.82926827 |
68 | leukocyte apoptotic process (GO:0071887) | 2.82760253 |
69 | cellular response to virus (GO:0098586) | 2.81546200 |
70 | translation (GO:0006412) | 2.81465228 |
71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.80517945 |
72 | protein carboxylation (GO:0018214) | 2.80517945 |
73 | protein targeting to membrane (GO:0006612) | 2.78011675 |
74 | maturation of 5.8S rRNA (GO:0000460) | 2.76888672 |
75 | proline metabolic process (GO:0006560) | 2.76545055 |
76 | nucleoside transmembrane transport (GO:1901642) | 2.75847000 |
77 | translational elongation (GO:0006414) | 2.75648424 |
78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75278782 |
79 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.74719258 |
80 | negative regulation of viral release from host cell (GO:1902187) | 2.74518332 |
81 | 4-hydroxyproline metabolic process (GO:0019471) | 2.72899458 |
82 | * nucleotide-sugar biosynthetic process (GO:0009226) | 2.72149970 |
83 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70217953 |
84 | nucleotide transmembrane transport (GO:1901679) | 2.70182723 |
85 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.67635761 |
86 | adenine nucleotide transport (GO:0051503) | 2.67438959 |
87 | cell redox homeostasis (GO:0045454) | 2.65805178 |
88 | regulation of translational termination (GO:0006449) | 2.64975050 |
89 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.64951514 |
90 | regulation of defense response to virus by host (GO:0050691) | 2.63519384 |
91 | digestion (GO:0007586) | 2.63487436 |
92 | positive regulation of protein kinase C signaling (GO:0090037) | 2.62824449 |
93 | necroptotic process (GO:0070266) | 2.61757342 |
94 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.61042399 |
95 | ribosomal small subunit biogenesis (GO:0042274) | 2.60578295 |
96 | N-acetylneuraminate metabolic process (GO:0006054) | 2.59649588 |
97 | positive regulation of defense response to virus by host (GO:0002230) | 2.59051798 |
98 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.56963724 |
99 | L-phenylalanine metabolic process (GO:0006558) | 2.56963724 |
100 | response to testosterone (GO:0033574) | 2.56718693 |
101 | zinc ion transport (GO:0006829) | 2.55700129 |
102 | meiotic chromosome segregation (GO:0045132) | 2.55237915 |
103 | galactose catabolic process (GO:0019388) | 2.53689768 |
104 | cellular zinc ion homeostasis (GO:0006882) | 2.53126274 |
105 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.52969394 |
106 | intestinal epithelial cell development (GO:0060576) | 2.52439197 |
107 | regulation of viral release from host cell (GO:1902186) | 2.51805462 |
108 | necrotic cell death (GO:0070265) | 2.50498987 |
109 | viral life cycle (GO:0019058) | 2.49627109 |
110 | translational initiation (GO:0006413) | 2.49626789 |
111 | pseudouridine synthesis (GO:0001522) | 2.48982536 |
112 | purine nucleotide salvage (GO:0032261) | 2.48624476 |
113 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.47739283 |
114 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.47366788 |
115 | regulation of chemokine biosynthetic process (GO:0045073) | 2.47261656 |
116 | mitotic cell cycle arrest (GO:0071850) | 2.46883855 |
117 | sphingomyelin metabolic process (GO:0006684) | 2.46842420 |
118 | transcytosis (GO:0045056) | 2.46499967 |
119 | mannosylation (GO:0097502) | 2.43204424 |
120 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.41978724 |
121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41978724 |
122 | nuclear envelope reassembly (GO:0031468) | 2.41335545 |
123 | mitotic nuclear envelope reassembly (GO:0007084) | 2.41335545 |
124 | valine metabolic process (GO:0006573) | 2.40857819 |
125 | purine nucleotide transport (GO:0015865) | 2.37818239 |
126 | myeloid dendritic cell differentiation (GO:0043011) | 2.36793641 |
127 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36503095 |
128 | lymphocyte apoptotic process (GO:0070227) | 2.36155604 |
129 | L-methionine salvage (GO:0071267) | 2.35909731 |
130 | L-methionine biosynthetic process (GO:0071265) | 2.35909731 |
131 | amino acid salvage (GO:0043102) | 2.35909731 |
132 | regulation of mitochondrial translation (GO:0070129) | 2.34941535 |
133 | adenosine receptor signaling pathway (GO:0001973) | 2.34165409 |
134 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.33589800 |
135 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.33526087 |
136 | diol metabolic process (GO:0034311) | 2.31937307 |
137 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.31549231 |
138 | regulation of vitamin metabolic process (GO:0030656) | 2.31404799 |
139 | * nucleotide-sugar metabolic process (GO:0009225) | 2.30921114 |
140 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.30766280 |
141 | UMP biosynthetic process (GO:0006222) | 2.30766280 |
142 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.30766280 |
143 | UMP metabolic process (GO:0046049) | 2.30766280 |
144 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.30071353 |
145 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.30002890 |
146 | T cell apoptotic process (GO:0070231) | 2.29757677 |
147 | glandular epithelial cell differentiation (GO:0002067) | 2.29164451 |
148 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.28687404 |
149 | heme biosynthetic process (GO:0006783) | 2.28146072 |
150 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.27871660 |
151 | L-phenylalanine catabolic process (GO:0006559) | 2.27871660 |
152 | cellular protein complex disassembly (GO:0043624) | 2.27019841 |
153 | tRNA modification (GO:0006400) | 2.26544606 |
154 | protein-cofactor linkage (GO:0018065) | 2.25942337 |
155 | folic acid metabolic process (GO:0046655) | 2.25664563 |
156 | negative regulation of cell size (GO:0045792) | 2.25586161 |
157 | negative regulation of B cell apoptotic process (GO:0002903) | 2.24983475 |
158 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.24791075 |
159 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.24465934 |
160 | peptidyl-proline hydroxylation (GO:0019511) | 2.24226768 |
161 | maturation of SSU-rRNA (GO:0030490) | 2.22021405 |
162 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 2.18738564 |
163 | sphingosine metabolic process (GO:0006670) | 2.18567638 |
164 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.18019472 |
165 | negative regulation of response to biotic stimulus (GO:0002832) | 2.17441105 |
166 | response to type I interferon (GO:0034340) | 2.16479981 |
167 | regulation of podosome assembly (GO:0071801) | 2.15551250 |
168 | regulation of B cell apoptotic process (GO:0002902) | 2.15444841 |
169 | T cell lineage commitment (GO:0002360) | 2.13913459 |
170 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.10711784 |
171 | defense response to protozoan (GO:0042832) | 2.10562678 |
172 | type I interferon signaling pathway (GO:0060337) | 2.09534627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.14402487 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99721118 |
3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.90784707 |
4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.90078058 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.89501810 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.85702613 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83404612 |
8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.83214088 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63989773 |
10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.57198048 |
11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46189040 |
12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.44010287 |
13 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.40106105 |
14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.36971761 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18287191 |
16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.17368536 |
17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.14681623 |
18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05627257 |
19 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.02771766 |
20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.01151286 |
21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95699949 |
22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.94090116 |
23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93755437 |
24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85168346 |
25 | P68_20966046_ChIP-Seq_HELA_Human | 1.84622933 |
26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84327225 |
27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.82492694 |
28 | MAF_26560356_Chip-Seq_TH1_Human | 1.80837658 |
29 | MAF_26560356_Chip-Seq_TH2_Human | 1.79184139 |
30 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78879798 |
31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77069288 |
32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77055622 |
33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75623129 |
34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.73868374 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71511490 |
36 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71464889 |
37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70812900 |
38 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69166871 |
39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68438746 |
40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66580310 |
41 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.66136482 |
42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.61472163 |
43 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.59856128 |
44 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.59697548 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58623519 |
46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57645589 |
47 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57333108 |
48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56185999 |
49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55640498 |
50 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.54815674 |
51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54687084 |
52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52577483 |
53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49803762 |
54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49786459 |
55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49164087 |
56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48930432 |
57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48531128 |
58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48162880 |
59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46390792 |
60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46012428 |
61 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.44926681 |
62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.43094621 |
63 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40639537 |
64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39740257 |
65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37834045 |
66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37306904 |
67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.36287156 |
68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35858134 |
69 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.35741674 |
70 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.34884149 |
71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34722782 |
72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34398813 |
73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33503978 |
74 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33291284 |
75 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.31664831 |
76 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31417065 |
77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30934400 |
78 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30548774 |
79 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.30516836 |
80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29983111 |
81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28858813 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27080152 |
83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27062033 |
84 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26115187 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25642874 |
86 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24903250 |
87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24691244 |
88 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23924640 |
89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22735324 |
90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22540225 |
91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22215104 |
92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22090588 |
93 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.21485767 |
94 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20870071 |
95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19718452 |
96 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18931428 |
97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18535803 |
98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18351638 |
99 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18094055 |
100 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18054072 |
101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17487542 |
102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17428005 |
103 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.17348081 |
104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17259129 |
105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16725991 |
106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16129149 |
107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16030023 |
108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15434403 |
109 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15021548 |
110 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13576956 |
111 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13556039 |
112 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13263251 |
113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13228667 |
114 | MYC_22102868_ChIP-Seq_BL_Human | 1.13065559 |
115 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11830212 |
116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11736930 |
117 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11422738 |
118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11089792 |
119 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11062417 |
120 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11052920 |
121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10610120 |
122 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10496556 |
123 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10015842 |
124 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09801956 |
125 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.09417117 |
126 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09346903 |
127 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09177567 |
128 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08420899 |
129 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08109171 |
130 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08025065 |
131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07009867 |
132 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06009101 |
133 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04650792 |
134 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04557530 |
135 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03113626 |
136 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03111021 |
137 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02926203 |
138 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01468759 |
139 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00808443 |
140 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00798084 |
141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99652950 |
142 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99338525 |
143 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97733239 |
144 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95799057 |
145 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95212301 |
146 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93889594 |
147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93816097 |
148 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.93812940 |
149 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91585960 |
150 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91487103 |
151 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89474978 |
152 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87411882 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001666_abnormal_nutrient_absorption | 3.36500111 |
2 | MP0005220_abnormal_exocrine_pancreas | 3.04526266 |
3 | MP0005451_abnormal_body_composition | 2.83617568 |
4 | MP0002877_abnormal_melanocyte_morpholog | 2.79296104 |
5 | MP0005083_abnormal_biliary_tract | 2.69968990 |
6 | MP0010234_abnormal_vibrissa_follicle | 2.63428953 |
7 | MP0005365_abnormal_bile_salt | 2.59821822 |
8 | MP0002139_abnormal_hepatobiliary_system | 2.58257278 |
9 | MP0002693_abnormal_pancreas_physiology | 2.50939144 |
10 | MP0005360_urolithiasis | 2.49194566 |
11 | MP0003195_calcinosis | 2.35735244 |
12 | MP0003693_abnormal_embryo_hatching | 2.33576255 |
13 | MP0006054_spinal_hemorrhage | 2.33130526 |
14 | MP0005076_abnormal_cell_differentiation | 2.30758770 |
15 | MP0003806_abnormal_nucleotide_metabolis | 2.24730817 |
16 | MP0008438_abnormal_cutaneous_collagen | 2.13942114 |
17 | MP0005085_abnormal_gallbladder_physiolo | 2.11459219 |
18 | MP0001944_abnormal_pancreas_morphology | 2.05964910 |
19 | MP0003453_abnormal_keratinocyte_physiol | 1.92251093 |
20 | MP0003436_decreased_susceptibility_to | 1.90616303 |
21 | MP0009840_abnormal_foam_cell | 1.90493240 |
22 | MP0003111_abnormal_nucleus_morphology | 1.90221754 |
23 | MP0010386_abnormal_urinary_bladder | 1.86875276 |
24 | MP0003724_increased_susceptibility_to | 1.84581021 |
25 | MP0003705_abnormal_hypodermis_morpholog | 1.82751718 |
26 | MP0005171_absent_coat_pigmentation | 1.81022831 |
27 | MP0005174_abnormal_tail_pigmentation | 1.80674996 |
28 | MP0000003_abnormal_adipose_tissue | 1.62494576 |
29 | MP0000013_abnormal_adipose_tissue | 1.59544065 |
30 | MP0009643_abnormal_urine_homeostasis | 1.55042715 |
31 | MP0005058_abnormal_lysosome_morphology | 1.54713750 |
32 | MP0002148_abnormal_hypersensitivity_rea | 1.53274390 |
33 | MP0009333_abnormal_splenocyte_physiolog | 1.49531349 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.49113387 |
35 | MP0003186_abnormal_redox_activity | 1.48908156 |
36 | MP0004264_abnormal_extraembryonic_tissu | 1.48239476 |
37 | MP0003868_abnormal_feces_composition | 1.47514380 |
38 | MP0003300_gastrointestinal_ulcer | 1.41363057 |
39 | MP0005084_abnormal_gallbladder_morpholo | 1.40575042 |
40 | MP0009785_altered_susceptibility_to | 1.40269822 |
41 | MP0003183_abnormal_peptide_metabolism | 1.39454793 |
42 | MP0005310_abnormal_salivary_gland | 1.38903863 |
43 | MP0000015_abnormal_ear_pigmentation | 1.37303557 |
44 | MP0001533_abnormal_skeleton_physiology | 1.35064623 |
45 | MP0000490_abnormal_crypts_of | 1.34306677 |
46 | MP0002254_reproductive_system_inflammat | 1.33555518 |
47 | MP0005501_abnormal_skin_physiology | 1.32320057 |
48 | MP0000858_altered_metastatic_potential | 1.31352769 |
49 | MP0003252_abnormal_bile_duct | 1.30622128 |
50 | MP0001845_abnormal_inflammatory_respons | 1.29714159 |
51 | MP0004043_abnormal_pH_regulation | 1.29408221 |
52 | MP0003283_abnormal_digestive_organ | 1.27657157 |
53 | MP0005636_abnormal_mineral_homeostasis | 1.27191902 |
54 | MP0008469_abnormal_protein_level | 1.26707499 |
55 | MP0000613_abnormal_salivary_gland | 1.25509998 |
56 | MP0003866_abnormal_defecation | 1.24766711 |
57 | MP0010155_abnormal_intestine_physiology | 1.23939906 |
58 | MP0001542_abnormal_bone_strength | 1.23701318 |
59 | MP0000685_abnormal_immune_system | 1.22917889 |
60 | MP0003566_abnormal_cell_adhesion | 1.21288015 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.19297048 |
62 | MP0005408_hypopigmentation | 1.19137440 |
63 | MP0005000_abnormal_immune_tolerance | 1.18620483 |
64 | MP0000678_abnormal_parathyroid_gland | 1.17741377 |
65 | MP0005025_abnormal_response_to | 1.15914020 |
66 | MP0001216_abnormal_epidermal_layer | 1.15386068 |
67 | MP0001661_extended_life_span | 1.15258136 |
68 | MP0010352_gastrointestinal_tract_polyps | 1.14649676 |
69 | MP0003448_altered_tumor_morphology | 1.13623599 |
70 | MP0005023_abnormal_wound_healing | 1.11458516 |
71 | MP0005257_abnormal_intraocular_pressure | 1.10604301 |
72 | MP0002078_abnormal_glucose_homeostasis | 1.10224453 |
73 | MP0001756_abnormal_urination | 1.09294241 |
74 | MP0005671_abnormal_response_to | 1.09067421 |
75 | MP0005319_abnormal_enzyme/_coenzyme | 1.08752112 |
76 | MP0005332_abnormal_amino_acid | 1.08750415 |
77 | MP0003763_abnormal_thymus_physiology | 1.08324803 |
78 | MP0002419_abnormal_innate_immunity | 1.07455379 |
79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06346555 |
80 | MP0003091_abnormal_cell_migration | 1.05911549 |
81 | MP0002019_abnormal_tumor_incidence | 1.05153626 |
82 | MP0000609_abnormal_liver_physiology | 1.04944836 |
83 | MP0001764_abnormal_homeostasis | 1.04655725 |
84 | MP0003303_peritoneal_inflammation | 1.04366825 |
85 | MP0001835_abnormal_antigen_presentation | 1.04313461 |
86 | MP0002166_altered_tumor_susceptibility | 1.04128134 |
87 | MP0009379_abnormal_foot_pigmentation | 1.04127258 |
88 | MP0004858_abnormal_nervous_system | 1.03413807 |
89 | MP0003172_abnormal_lysosome_physiology | 1.03048237 |
90 | MP0000470_abnormal_stomach_morphology | 1.02472501 |
91 | MP0010094_abnormal_chromosome_stability | 1.02369414 |
92 | MP0003795_abnormal_bone_structure | 1.02215040 |
93 | MP0002876_abnormal_thyroid_physiology | 1.01136205 |
94 | MP0004947_skin_inflammation | 1.01076524 |
95 | MP0009278_abnormal_bone_marrow | 1.00963760 |
96 | MP0002060_abnormal_skin_morphology | 1.00911463 |
97 | MP0005275_abnormal_skin_tensile | 1.00454528 |
98 | MP0003077_abnormal_cell_cycle | 0.99611534 |
99 | MP0001986_abnormal_taste_sensitivity | 0.98352719 |
100 | MP0001881_abnormal_mammary_gland | 0.97880769 |
101 | MP0001958_emphysema | 0.97685850 |
102 | MP0002006_tumorigenesis | 0.97147359 |
103 | MP0003718_maternal_effect | 0.96851223 |
104 | MP0010329_abnormal_lipoprotein_level | 0.96815250 |
105 | MP0003786_premature_aging | 0.96480460 |
106 | MP0002796_impaired_skin_barrier | 0.96138923 |
107 | MP0000538_abnormal_urinary_bladder | 0.95669529 |
108 | MP0009931_abnormal_skin_appearance | 0.94691579 |
109 | MP0005409_darkened_coat_color | 0.94651267 |
110 | MP0001243_abnormal_dermal_layer | 0.94521672 |
111 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94323937 |
112 | MP0005390_skeleton_phenotype | 0.93190799 |
113 | MP0001873_stomach_inflammation | 0.93057530 |
114 | MP0002405_respiratory_system_inflammati | 0.92653555 |
115 | MP0005503_abnormal_tendon_morphology | 0.92562109 |
116 | MP0002933_joint_inflammation | 0.92474728 |
117 | MP0000358_abnormal_cell_content/ | 0.92330413 |
118 | MP0004782_abnormal_surfactant_physiolog | 0.91154291 |
119 | MP0002723_abnormal_immune_serum | 0.90638600 |
120 | MP0002452_abnormal_antigen_presenting | 0.89467255 |
121 | MP0005387_immune_system_phenotype | 0.89041778 |
122 | MP0001790_abnormal_immune_system | 0.89041778 |
123 | MP0003045_fibrosis | 0.88959795 |
124 | MP0004957_abnormal_blastocyst_morpholog | 0.88298924 |
125 | MP0010307_abnormal_tumor_latency | 0.88076468 |
126 | MP0004019_abnormal_vitamin_homeostasis | 0.88070737 |
127 | MP0002429_abnormal_blood_cell | 0.87931163 |
128 | MP0002136_abnormal_kidney_physiology | 0.86970040 |
129 | MP0002398_abnormal_bone_marrow | 0.86796068 |
130 | MP0002896_abnormal_bone_mineralization | 0.86358715 |
131 | MP0002722_abnormal_immune_system | 0.84121892 |
132 | MP0002118_abnormal_lipid_homeostasis | 0.83998859 |
133 | MP0003279_aneurysm | 0.82984365 |
134 | MP0001765_abnormal_ion_homeostasis | 0.82980660 |
135 | MP0000716_abnormal_immune_system | 0.82486951 |
136 | MP0005464_abnormal_platelet_physiology | 0.80467530 |
137 | MP0008004_abnormal_stomach_pH | 0.80256017 |
138 | MP0001800_abnormal_humoral_immune | 0.80173919 |
139 | MP0001819_abnormal_immune_cell | 0.79676649 |
140 | MP0002420_abnormal_adaptive_immunity | 0.78728125 |
141 | MP0000598_abnormal_liver_morphology | 0.77564414 |
142 | MP0005379_endocrine/exocrine_gland_phen | 0.77440875 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Testicular atrophy (HP:0000029) | 5.01222586 |
2 | Abnormality of the intrinsic pathway (HP:0010989) | 4.19704013 |
3 | Thin bony cortex (HP:0002753) | 4.19471173 |
4 | Poikiloderma (HP:0001029) | 3.92772200 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86742464 |
6 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82924731 |
7 | Vacuolated lymphocytes (HP:0001922) | 3.62325201 |
8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51505057 |
9 | Hypoglycemic coma (HP:0001325) | 3.51110893 |
10 | Ulnar bowing (HP:0003031) | 3.28886583 |
11 | Trismus (HP:0000211) | 3.22366164 |
12 | Squamous cell carcinoma (HP:0002860) | 3.21451469 |
13 | Hemorrhage of the eye (HP:0011885) | 3.16309722 |
14 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.11538812 |
15 | Hypoglycemic seizures (HP:0002173) | 3.10594495 |
16 | Symptomatic seizures (HP:0011145) | 2.90388954 |
17 | Late onset (HP:0003584) | 2.84818685 |
18 | Delayed epiphyseal ossification (HP:0002663) | 2.79296525 |
19 | Type I transferrin isoform profile (HP:0003642) | 2.75864177 |
20 | Vaginal fistula (HP:0004320) | 2.74864254 |
21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71631830 |
22 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71631830 |
23 | Abnormal protein glycosylation (HP:0012346) | 2.71631830 |
24 | Abnormal glycosylation (HP:0012345) | 2.71631830 |
25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.63480781 |
26 | Beaking of vertebral bodies (HP:0004568) | 2.63052575 |
27 | Decreased subcutaneous fat (HP:0001002) | 2.60658511 |
28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56965830 |
29 | Ketoacidosis (HP:0001993) | 2.56727873 |
30 | Gastrointestinal infarctions (HP:0005244) | 2.54572067 |
31 | Intestinal fistula (HP:0100819) | 2.53998186 |
32 | Malnutrition (HP:0004395) | 2.53661448 |
33 | Hyperglycemia (HP:0003074) | 2.53520043 |
34 | Carpal bone hypoplasia (HP:0001498) | 2.51905778 |
35 | Vertebral compression fractures (HP:0002953) | 2.51799681 |
36 | Premature rupture of membranes (HP:0001788) | 2.51265784 |
37 | Progressive muscle weakness (HP:0003323) | 2.50260588 |
38 | Rectovaginal fistula (HP:0000143) | 2.46666899 |
39 | Rectal fistula (HP:0100590) | 2.46666899 |
40 | Abnormal albumin level (HP:0012116) | 2.45666556 |
41 | Hypoalbuminemia (HP:0003073) | 2.45666556 |
42 | Glucose intolerance (HP:0000833) | 2.45462026 |
43 | Abnormality of DNA repair (HP:0003254) | 2.44430903 |
44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43047524 |
45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43047524 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43047524 |
47 | Hand muscle atrophy (HP:0009130) | 2.42430898 |
48 | Thoracolumbar scoliosis (HP:0002944) | 2.42429165 |
49 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.41971576 |
50 | Mesangial abnormality (HP:0001966) | 2.41631845 |
51 | Dysostosis multiplex (HP:0000943) | 2.41515888 |
52 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.40682179 |
53 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.40682179 |
54 | Abnormal trabecular bone morphology (HP:0100671) | 2.39703320 |
55 | Pustule (HP:0200039) | 2.38663976 |
56 | Abnormal hemoglobin (HP:0011902) | 2.38407314 |
57 | Methylmalonic aciduria (HP:0012120) | 2.37277639 |
58 | Nasal polyposis (HP:0100582) | 2.33743292 |
59 | Stridor (HP:0010307) | 2.33073491 |
60 | Fat malabsorption (HP:0002630) | 2.30885369 |
61 | Abdominal distention (HP:0003270) | 2.29672971 |
62 | Abnormality of the nasal mucosa (HP:0000433) | 2.28364788 |
63 | Absent thumb (HP:0009777) | 2.27909510 |
64 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.26277473 |
65 | Type I diabetes mellitus (HP:0100651) | 2.26139620 |
66 | Entropion (HP:0000621) | 2.22881648 |
67 | Reduced antithrombin III activity (HP:0001976) | 2.21821858 |
68 | Cheilitis (HP:0100825) | 2.20514552 |
69 | Microretrognathia (HP:0000308) | 2.18074444 |
70 | Exocrine pancreatic insufficiency (HP:0001738) | 2.17301361 |
71 | Ragged-red muscle fibers (HP:0003200) | 2.15963653 |
72 | Flattened epiphyses (HP:0003071) | 2.15697875 |
73 | Opisthotonus (HP:0002179) | 2.15477578 |
74 | Thrombocytosis (HP:0001894) | 2.14416842 |
75 | Abnormality of T cell physiology (HP:0011840) | 2.14144363 |
76 | Menorrhagia (HP:0000132) | 2.14099652 |
77 | Facial diplegia (HP:0001349) | 2.12918741 |
78 | Bowing of the arm (HP:0006488) | 2.12810378 |
79 | Bowed forearm bones (HP:0003956) | 2.12810378 |
80 | Prolonged partial thromboplastin time (HP:0003645) | 2.12081050 |
81 | Generalized aminoaciduria (HP:0002909) | 2.12027887 |
82 | Rib fusion (HP:0000902) | 2.11148952 |
83 | Joint stiffness (HP:0001387) | 2.10530498 |
84 | Biconcave vertebral bodies (HP:0004586) | 2.08723081 |
85 | Hepatic necrosis (HP:0002605) | 2.08147632 |
86 | Microvesicular hepatic steatosis (HP:0001414) | 2.07193413 |
87 | Homocystinuria (HP:0002156) | 2.07104907 |
88 | Abnormality of homocysteine metabolism (HP:0010919) | 2.07104907 |
89 | Pancreatitis (HP:0001733) | 2.07066642 |
90 | Abnormal pancreas size (HP:0012094) | 2.07003340 |
91 | Aplasia of the musculature (HP:0100854) | 2.06526516 |
92 | Macrocytic anemia (HP:0001972) | 2.06367529 |
93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.05811929 |
94 | Mucopolysacchariduria (HP:0008155) | 2.04187273 |
95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04187273 |
96 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.03651160 |
97 | Xanthomatosis (HP:0000991) | 2.02481846 |
98 | Insulin resistance (HP:0000855) | 2.01110507 |
99 | Rough bone trabeculation (HP:0100670) | 1.99596330 |
100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98866786 |
101 | Intrahepatic cholestasis (HP:0001406) | 1.95874416 |
102 | Elevated alkaline phosphatase (HP:0003155) | 1.95798645 |
103 | Abnormal glucose tolerance (HP:0001952) | 1.95434100 |
104 | Premature graying of hair (HP:0002216) | 1.94583188 |
105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93615187 |
106 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.92875175 |
107 | Villous atrophy (HP:0011473) | 1.92875175 |
108 | Abnormality of the anterior horn cell (HP:0006802) | 1.92210628 |
109 | Degeneration of anterior horn cells (HP:0002398) | 1.92210628 |
110 | Metaphyseal irregularity (HP:0003025) | 1.92184366 |
111 | Methylmalonic acidemia (HP:0002912) | 1.92047519 |
112 | Hyperacusis (HP:0010780) | 1.91617894 |
113 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91284451 |
114 | Hypobetalipoproteinemia (HP:0003563) | 1.91125534 |
115 | Irregular vertebral endplates (HP:0003301) | 1.89271305 |
116 | Attenuation of retinal blood vessels (HP:0007843) | 1.88847435 |
117 | Protrusio acetabuli (HP:0003179) | 1.88495011 |
118 | Megaloblastic anemia (HP:0001889) | 1.86907602 |
119 | Genu recurvatum (HP:0002816) | 1.86750468 |
120 | Flat occiput (HP:0005469) | 1.86148395 |
121 | Ketosis (HP:0001946) | 1.84768315 |
122 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.84517568 |
123 | Abnormality of purine metabolism (HP:0004352) | 1.84030132 |
124 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83978116 |
125 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83978116 |
126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83978116 |
127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83816567 |
128 | Basal cell carcinoma (HP:0002671) | 1.83561750 |
129 | Anorexia (HP:0002039) | 1.82906940 |
130 | Increased serum ferritin (HP:0003281) | 1.81928276 |
131 | Abnormal tarsal ossification (HP:0008369) | 1.81671820 |
132 | Enlarged epiphyses (HP:0010580) | 1.81090126 |
133 | Hypertensive crisis (HP:0100735) | 1.80019634 |
134 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79247260 |
135 | Large for gestational age (HP:0001520) | 1.78582999 |
136 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77742860 |
137 | Cervical subluxation (HP:0003308) | 1.76768588 |
138 | Multiple enchondromatosis (HP:0005701) | 1.75191809 |
139 | IgA deficiency (HP:0002720) | 1.73984307 |
140 | Emphysema (HP:0002097) | 1.73825927 |
141 | Gout (HP:0001997) | 1.73779772 |
142 | Periodontitis (HP:0000704) | 1.72035829 |
143 | Eczematoid dermatitis (HP:0000976) | 1.71929934 |
144 | Recurrent cutaneous fungal infections (HP:0011370) | 1.70998087 |
145 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.70998087 |
146 | Colitis (HP:0002583) | 1.70549362 |
147 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.70160189 |
148 | Abnormality of the costochondral junction (HP:0000919) | 1.70075797 |
149 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70052401 |
150 | Abnormal pupillary function (HP:0007686) | 1.70035313 |
151 | Nonimmune hydrops fetalis (HP:0001790) | 1.69839766 |
152 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.69418700 |
153 | Joint hemorrhage (HP:0005261) | 1.68545062 |
154 | Popliteal pterygium (HP:0009756) | 1.68023535 |
155 | Anteriorly placed anus (HP:0001545) | 1.67689531 |
156 | Flat capital femoral epiphysis (HP:0003370) | 1.66967731 |
157 | Abnormality of nucleobase metabolism (HP:0010932) | 1.66809360 |
158 | Widely patent fontanelles and sutures (HP:0004492) | 1.66106469 |
159 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.65901405 |
160 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.65901405 |
161 | Short thumb (HP:0009778) | 1.65538855 |
162 | Steatorrhea (HP:0002570) | 1.65405990 |
163 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.65379454 |
164 | Progressive neurologic deterioration (HP:0002344) | 1.65330229 |
165 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.65016010 |
166 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.64409392 |
167 | Dicarboxylic aciduria (HP:0003215) | 1.64409392 |
168 | Abnormal epiphyseal ossification (HP:0010656) | 1.64388070 |
169 | Flat acetabular roof (HP:0003180) | 1.64126735 |
170 | Hypergonadotropic hypogonadism (HP:0000815) | 1.62275033 |
171 | Stomatitis (HP:0010280) | 1.60810887 |
172 | Thoracic kyphosis (HP:0002942) | 1.60797435 |
173 | Patellar aplasia (HP:0006443) | 1.60065570 |
174 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.59561867 |
175 | Decreased circulating renin level (HP:0003351) | 1.59559256 |
176 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.56434734 |
177 | Hypoproteinemia (HP:0003075) | 1.55236191 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.59872875 |
2 | MAPKAPK3 | 4.55766793 |
3 | EEF2K | 4.07757207 |
4 | NME2 | 3.37060952 |
5 | SMG1 | 3.05227122 |
6 | BCKDK | 2.91952628 |
7 | TRIB3 | 2.60905235 |
8 | EIF2AK3 | 2.44370541 |
9 | ZAK | 2.43755330 |
10 | IRAK3 | 2.31179773 |
11 | TLK1 | 2.23302982 |
12 | PIM2 | 2.15907164 |
13 | STK16 | 1.97645432 |
14 | RPS6KB2 | 1.96737898 |
15 | PASK | 1.92337224 |
16 | INSRR | 1.75028991 |
17 | TBK1 | 1.72277607 |
18 | TESK2 | 1.71422724 |
19 | EIF2AK1 | 1.69167188 |
20 | MST4 | 1.67836223 |
21 | EPHA2 | 1.67457234 |
22 | TAOK3 | 1.66675111 |
23 | MAP3K11 | 1.65651434 |
24 | TESK1 | 1.64935359 |
25 | IRAK4 | 1.54546310 |
26 | MAP2K3 | 1.52808797 |
27 | MAP2K2 | 1.47497113 |
28 | TRPM7 | 1.44797817 |
29 | ICK | 1.44441100 |
30 | FLT3 | 1.39238516 |
31 | FRK | 1.38157010 |
32 | PRPF4B | 1.36241984 |
33 | BUB1 | 1.33774729 |
34 | MAPKAPK5 | 1.30928845 |
35 | JAK3 | 1.29626669 |
36 | NME1 | 1.28574085 |
37 | TSSK6 | 1.27561954 |
38 | MAP3K3 | 1.25609323 |
39 | CDK12 | 1.23283792 |
40 | MAP4K1 | 1.20821807 |
41 | VRK2 | 1.17981896 |
42 | MAPK15 | 1.14979636 |
43 | ZAP70 | 1.14633318 |
44 | IRAK1 | 1.13900640 |
45 | TYK2 | 1.11356568 |
46 | KDR | 1.08928310 |
47 | CDK4 | 1.08908505 |
48 | NLK | 1.06250206 |
49 | ARAF | 1.02675742 |
50 | BRAF | 1.00875234 |
51 | PRKD2 | 0.97903206 |
52 | SCYL2 | 0.96801725 |
53 | TAOK2 | 0.94954866 |
54 | HIPK2 | 0.93447927 |
55 | PRKCI | 0.92838492 |
56 | ILK | 0.92530250 |
57 | AURKA | 0.89111438 |
58 | MAP2K6 | 0.84408206 |
59 | TAOK1 | 0.84359008 |
60 | AKT3 | 0.82831119 |
61 | MAP3K14 | 0.82121393 |
62 | RPS6KA4 | 0.82104494 |
63 | NEK9 | 0.81010710 |
64 | MST1R | 0.80534047 |
65 | CAMK1D | 0.79768882 |
66 | STK10 | 0.79426775 |
67 | CDC42BPA | 0.79337948 |
68 | PIK3CG | 0.79301045 |
69 | VRK1 | 0.78221848 |
70 | FGFR4 | 0.78164428 |
71 | PBK | 0.77215857 |
72 | MYLK | 0.74541841 |
73 | RPS6KL1 | 0.74447670 |
74 | RPS6KC1 | 0.74447670 |
75 | IRAK2 | 0.73265152 |
76 | MAPK11 | 0.72019993 |
77 | PDPK1 | 0.69743758 |
78 | LMTK2 | 0.69471019 |
79 | IKBKE | 0.69079326 |
80 | RPS6KA6 | 0.68531965 |
81 | BLK | 0.68352867 |
82 | MAP3K6 | 0.67580857 |
83 | PTK6 | 0.66175772 |
84 | CHEK2 | 0.64715061 |
85 | EPHA3 | 0.64319842 |
86 | MUSK | 0.63504606 |
87 | IKBKB | 0.63030703 |
88 | MELK | 0.62011376 |
89 | RPS6KA2 | 0.61749525 |
90 | EPHB1 | 0.61676584 |
91 | PDK2 | 0.60900750 |
92 | MAP3K10 | 0.58783747 |
93 | SIK2 | 0.57367414 |
94 | SIK3 | 0.56758194 |
95 | BRSK2 | 0.56651086 |
96 | MET | 0.56383892 |
97 | CLK1 | 0.54013928 |
98 | ATR | 0.52810450 |
99 | MTOR | 0.52331464 |
100 | CSK | 0.51778472 |
101 | TEC | 0.50991407 |
102 | PDGFRA | 0.50732024 |
103 | WNK4 | 0.50023242 |
104 | PRKG2 | 0.48024141 |
105 | PKN2 | 0.47701135 |
106 | PTK2 | 0.47699679 |
107 | MAP3K1 | 0.47597361 |
108 | ABL2 | 0.47392135 |
109 | LIMK1 | 0.47309123 |
110 | AKT2 | 0.46942652 |
111 | SIK1 | 0.46805224 |
112 | RPS6KA5 | 0.46698815 |
113 | MAPKAPK2 | 0.45337659 |
114 | STK4 | 0.44642075 |
115 | LRRK2 | 0.44620314 |
116 | TTN | 0.43743912 |
117 | GRK5 | 0.43493648 |
118 | CDK7 | 0.42741612 |
119 | CDK6 | 0.42109484 |
120 | MAP3K8 | 0.40650360 |
121 | GRK6 | 0.40458629 |
122 | PIM1 | 0.40335313 |
123 | CDK8 | 0.40007270 |
124 | DYRK3 | 0.39436983 |
125 | MAP3K13 | 0.39208739 |
126 | WEE1 | 0.39160443 |
127 | MAP3K2 | 0.37890658 |
128 | DAPK3 | 0.37536150 |
129 | TTK | 0.36682455 |
130 | PAK1 | 0.35133241 |
131 | PAK2 | 0.33827901 |
132 | ITK | 0.31940919 |
133 | CHUK | 0.31554245 |
134 | TXK | 0.30367849 |
135 | BTK | 0.30253781 |
136 | PRKD3 | 0.30177835 |
137 | LCK | 0.29600128 |
138 | SRPK1 | 0.29566607 |
139 | PAK4 | 0.29488455 |
140 | LYN | 0.29132564 |
141 | JAK1 | 0.28639371 |
142 | AURKB | 0.28614431 |
143 | SYK | 0.27427971 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 5.52884225 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.58503571 |
3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.76133621 |
4 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.22787815 |
5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.10488296 |
6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.55016795 |
7 | Ribosome_Homo sapiens_hsa03010 | 2.51232111 |
8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.47526791 |
9 | Sulfur relay system_Homo sapiens_hsa04122 | 2.42403289 |
10 | Proteasome_Homo sapiens_hsa03050 | 2.41281653 |
11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.30730019 |
12 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.08032753 |
13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.00049534 |
14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.84982319 |
15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79109191 |
16 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.77692733 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70662555 |
18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69917449 |
19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57891136 |
20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.57412124 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55250595 |
22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53643492 |
23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.47191636 |
24 | RNA polymerase_Homo sapiens_hsa03020 | 1.41996702 |
25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.37751207 |
26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.34689367 |
27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33118225 |
28 | Homologous recombination_Homo sapiens_hsa03440 | 1.31868262 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29857163 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29776368 |
31 | Legionellosis_Homo sapiens_hsa05134 | 1.26674965 |
32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24790018 |
33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.24484099 |
34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.23937905 |
35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23001531 |
36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20265904 |
37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19620584 |
38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19152441 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18160730 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12524611 |
41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11372555 |
42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07605102 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07134507 |
44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06425345 |
45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00774690 |
46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.00258756 |
47 | Hepatitis C_Homo sapiens_hsa05160 | 0.98949883 |
48 | Bladder cancer_Homo sapiens_hsa05219 | 0.98548666 |
49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96092985 |
50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94960727 |
51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94062840 |
52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89630382 |
53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89629029 |
54 | Lysosome_Homo sapiens_hsa04142 | 0.89384153 |
55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88495580 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86080640 |
57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82887646 |
58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80103103 |
59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77447132 |
60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77125483 |
61 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76941196 |
62 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76933637 |
63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75925734 |
64 | Base excision repair_Homo sapiens_hsa03410 | 0.75675888 |
65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75673962 |
66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74109179 |
67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73851558 |
68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73669494 |
69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70923344 |
70 | Peroxisome_Homo sapiens_hsa04146 | 0.69403266 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.68228905 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68210104 |
73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66135876 |
74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.65263227 |
75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65223754 |
76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64143243 |
77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62948241 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62857421 |
79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61920502 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61731427 |
81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61661391 |
82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61365214 |
83 | Asthma_Homo sapiens_hsa05310 | 0.60851476 |
84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60197306 |
85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60100767 |
86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.59939401 |
87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59492125 |
88 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.59009799 |
89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58319881 |
90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58306816 |
91 | DNA replication_Homo sapiens_hsa03030 | 0.57722052 |
92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57182544 |
93 | Influenza A_Homo sapiens_hsa05164 | 0.56756196 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55635329 |
95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55067325 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53751958 |
97 | Hepatitis B_Homo sapiens_hsa05161 | 0.53229919 |
98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52517363 |
99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52359227 |
100 | Mismatch repair_Homo sapiens_hsa03430 | 0.51905200 |
101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51778135 |
102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50793662 |
103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50150394 |
104 | Purine metabolism_Homo sapiens_hsa00230 | 0.48761155 |
105 | Malaria_Homo sapiens_hsa05144 | 0.47256788 |
106 | Measles_Homo sapiens_hsa05162 | 0.47087062 |
107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46499906 |
108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46223076 |
109 | Prion diseases_Homo sapiens_hsa05020 | 0.45002015 |
110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44809306 |
111 | Spliceosome_Homo sapiens_hsa03040 | 0.44576133 |
112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44453850 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.44353906 |
114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43812922 |
115 | Allograft rejection_Homo sapiens_hsa05330 | 0.43809635 |
116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42226840 |
117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41671078 |
118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41130262 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40827550 |
120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40630233 |
121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39558970 |
122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39090446 |
123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39075477 |
124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38857197 |
125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38503053 |
126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38237475 |
127 | Apoptosis_Homo sapiens_hsa04210 | 0.37055360 |
128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36946331 |
129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36857707 |
130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36710234 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36172959 |
132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36043667 |
133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35971136 |
134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35857095 |
135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35404404 |
136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34675684 |
137 | Tuberculosis_Homo sapiens_hsa05152 | 0.34277495 |
138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32946803 |
139 | Pertussis_Homo sapiens_hsa05133 | 0.32804542 |
140 | Prostate cancer_Homo sapiens_hsa05215 | 0.32454145 |